ATE511752T1 - Methode zur kontrolle der proliferation und differenzierung von stamm- und vorläuferzellen - Google Patents

Methode zur kontrolle der proliferation und differenzierung von stamm- und vorläuferzellen

Info

Publication number
ATE511752T1
ATE511752T1 AT99906799T AT99906799T ATE511752T1 AT E511752 T1 ATE511752 T1 AT E511752T1 AT 99906799 T AT99906799 T AT 99906799T AT 99906799 T AT99906799 T AT 99906799T AT E511752 T1 ATE511752 T1 AT E511752T1
Authority
AT
Austria
Prior art keywords
stem
stem cells
cells
progenicial
differentiation
Prior art date
Application number
AT99906799T
Other languages
English (en)
Inventor
Tony Peled
Eitan Fibach
Avi Treves
Mark Friedman
Original Assignee
Gamida Cell Ltd
Hadasit Med Res Service
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gamida Cell Ltd, Hadasit Med Res Service filed Critical Gamida Cell Ltd
Application granted granted Critical
Publication of ATE511752T1 publication Critical patent/ATE511752T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • C12N5/0647Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/20Transition metals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/20Transition metals
    • C12N2500/22Zinc; Zn chelators
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/125Stem cell factor [SCF], c-kit ligand [KL]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/145Thrombopoietin [TPO]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20Cytokines; Chemokines
    • C12N2501/23Interleukins [IL]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20Cytokines; Chemokines
    • C12N2501/26Flt-3 ligand (CD135L, flk-2 ligand)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT99906799T 1998-02-17 1999-02-08 Methode zur kontrolle der proliferation und differenzierung von stamm- und vorläuferzellen ATE511752T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2419598A 1998-02-17 1998-02-17
US13036798A 1998-08-07 1998-08-07
PCT/US1999/002664 WO1999040783A1 (en) 1998-02-17 1999-02-08 Method of controlling proliferation and differentiation of stem and progenitor cells

Publications (1)

Publication Number Publication Date
ATE511752T1 true ATE511752T1 (de) 2011-06-15

Family

ID=26698157

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99906799T ATE511752T1 (de) 1998-02-17 1999-02-08 Methode zur kontrolle der proliferation und differenzierung von stamm- und vorläuferzellen

Country Status (8)

Country Link
EP (2) EP1332673B1 (de)
JP (1) JP3810273B2 (de)
AT (1) ATE511752T1 (de)
AU (1) AU759522C (de)
CA (1) CA2320073C (de)
ES (1) ES2391055T3 (de)
IL (2) IL137757A0 (de)
WO (1) WO1999040783A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6962698B1 (en) 1998-02-17 2005-11-08 Gamida Cell Ltd. Methods of controlling proliferation and differentiation of stem and progenitor cells
CA2344653A1 (en) 1998-09-29 2000-04-06 Gamida Cell Ltd. Methods of controlling proliferation and differentiation of stem and progenitor cells
NL1017973C2 (nl) * 2000-05-10 2002-11-08 Tristem Trading Cyprus Ltd Inrichting.
IL152904A0 (en) 2002-01-24 2003-06-24 Gamida Cell Ltd Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations
WO2003062404A1 (en) 2002-01-25 2003-07-31 Gamida-Cell Ltd. Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby
AU2004217699B2 (en) * 2003-03-07 2008-07-03 Gamida-Cell Ltd. Expansion of renewable stem cell populations using modulators of PI 3-kinase
IL161903A0 (en) * 2003-07-17 2005-11-20 Gamida Cell Ltd Ex vivo progenitor and stem cell expansion for usein the treatment of disease of endodermally- deri ved organs
WO2005007799A2 (en) * 2003-07-17 2005-01-27 Gamida-Cell Ltd. Methods for ex-vivo expanding stem/progenitor cells
JP2007535479A (ja) 2003-08-13 2007-12-06 チルドレンズ ホスピタル メディカル センター GTPaseを調節するためのキメラペプチド
US7417026B2 (en) 2003-08-13 2008-08-26 Children's Hospital Medical Center Mobilization of hematopoietic cells
EP1799812A4 (de) 2004-09-16 2009-09-09 Gamida Cell Ltd Verfahren zur ex-vivo-expansion von progenitor- und stammzellen durch gemeinsame kultivierung mit mesenchymzellen
US8846393B2 (en) 2005-11-29 2014-09-30 Gamida-Cell Ltd. Methods of improving stem cell homing and engraftment
WO2007108689A2 (en) * 2006-03-21 2007-09-27 Stichting Skeletal Tissue Engineering Method for induction of differentiation of stem and progenitor cells
JP5573160B2 (ja) 2007-12-05 2014-08-20 日産化学工業株式会社 ヘテロ環化合物による造血幹細胞の増幅方法
US9115341B2 (en) 2007-12-05 2015-08-25 Nissan Chemical Industries, Ltd. Method for expanding hematopoietic stem cells using heterocyclic compound
WO2009072624A1 (ja) 2007-12-05 2009-06-11 Nissan Chemical Industries, Ltd. ヘテロ環化合物による造血幹細胞の増幅方法
CN101889007A (zh) 2007-12-06 2010-11-17 日产化学工业株式会社 采用杂环化合物的造血干细胞的扩增方法
BRPI1014635A8 (pt) 2009-06-04 2016-10-11 Nissan Chemical Ind Ltd compostos heterocíclicos e agentes de expansão para células-tronco hematopoiéticas
EP2581442A4 (de) 2010-06-14 2013-11-06 Nissan Chemical Ind Ltd Verfahren zur herstellung blutbildender stammzellen
WO2012074068A1 (ja) 2010-12-01 2012-06-07 日産化学工業株式会社 ピラゾール化合物による造血幹細胞の製造方法
CN104204192A (zh) 2012-02-13 2014-12-10 加米达细胞有限公司 间充质干细胞调理的基质及其产生和使用方法
US9175266B2 (en) 2012-07-23 2015-11-03 Gamida Cell Ltd. Enhancement of natural killer (NK) cell proliferation and activity
US9567569B2 (en) 2012-07-23 2017-02-14 Gamida Cell Ltd. Methods of culturing and expanding mesenchymal stem cells
WO2021149127A1 (ja) * 2020-01-21 2021-07-29 オリンパス株式会社 赤血球分化モニタリング装置および赤血球分化モニタリング方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01222780A (ja) * 1988-03-02 1989-09-06 Tosoh Corp ウロキナーゼ前駆体様蛋白質のリフォールディング方法
US5631219A (en) * 1994-03-08 1997-05-20 Somatogen, Inc. Method of stimulating hematopoiesis with hemoglobin
JP2000513329A (ja) * 1996-03-01 2000-10-10 イムクローン システムズ インコーポレイテッド 幹細胞の分化を阻害させるためのデルタ様蛋白質の使用
JP2000507812A (ja) * 1996-03-12 2000-06-27 ライフ テクノロジーズ,インコーポレイテッド 造血細胞培養栄養補充成分
US6962698B1 (en) * 1998-02-17 2005-11-08 Gamida Cell Ltd. Methods of controlling proliferation and differentiation of stem and progenitor cells
CA2344653A1 (en) * 1998-09-29 2000-04-06 Gamida Cell Ltd. Methods of controlling proliferation and differentiation of stem and progenitor cells

Also Published As

Publication number Publication date
WO1999040783A1 (en) 1999-08-19
JP3810273B2 (ja) 2006-08-16
ES2391055T3 (es) 2012-11-21
EP1069821A4 (de) 2001-11-21
EP1332673A1 (de) 2003-08-06
IL137757A0 (en) 2001-10-31
AU759522B2 (en) 2003-04-17
EP1332673B1 (de) 2012-05-30
EP1069821A1 (de) 2001-01-24
EP1069821B1 (de) 2011-06-08
AU759522C (en) 2005-05-12
HK1057976A1 (en) 2004-04-30
CA2320073A1 (en) 1999-08-19
HK1034162A1 (en) 2001-10-19
CA2320073C (en) 2011-11-01
IL137757A (en) 2006-08-20
JP2002502617A (ja) 2002-01-29
AU2662499A (en) 1999-08-30

Similar Documents

Publication Publication Date Title
IL137757A0 (en) Method of controlling proliferation and differentiation of stem and progenitor cells
DE69928678D1 (de) Verwendung von wachstumsfaktoren und hormonen zur vermehrung menschlicher chondrozyten und knorpelgewebeherstellung
IL163180A (en) Growing populations of renewable hematopoietic stem cells and their methods
DE69737949D1 (de) Isolierung, vermehrung und gezielte differenzierung von zäugetierstammzellen des zentralnervensystems
DK0904351T3 (da) Dyreceller og fremgangsmåder til replikationen af influenzavirus
DE60007656D1 (de) Bindende hydrogele zum ersatz des nukleus pulposus
ATE311406T1 (de) Hemmstoff und stimulator der proliferation haematopoietischer stammzellen und deren anwendungen
HUP0101547A2 (hu) Szilárd táptalajú fermentor, valamint fermentációs eljárás szilárd táptalajjal
DK0477290T3 (da) Fremgangsmåder, sammensætninger og indretninger til dyrkning af celler
NO20006096D0 (no) Medium for dyrking av dyreceller og fremgangsmåte for fremstilling av protein ved anvendelse av det samme
DE60017875D1 (de) Verwendung von collagenase in der zubereitung von neuralen stammzellkulturen
ATE513209T1 (de) Grenzflächen-patch-clamp-verfahren und -gerät
DE69806232D1 (de) Verfahren zur vermehrung von haaren
DK0954596T3 (da) Foröget produktion af taxaner ved celledyrkning af Taxus-art
ATE309267T1 (de) Methode zur proliferation und differenzierung von b-zellen und verwendungen dafür
AU4017501A (en) Cell culture spinner flasks
DE50112626D1 (de) Verfahren zur kultivierung von knorpelersatz und biomatrix nach diesem verfahren hergestellt
WO2000070022A3 (en) Ex vivo expansion of mammalian hematopoietic stem cells
GB9825096D0 (en) Cells,culture methods and their uses
ATE449162T1 (de) Herstellung von tcr gamma delta t-zellen
ES2132025B1 (es) Proteinas urag de las plantas.
ATE190654T1 (de) Verwendung von dna oligomeren zur hemmung von hiv durch reduktion ribosomaler leserasterverschichtung
FR2625221B1 (fr) Protoplastes stabilises et procede pour leur obtention
DE69636755D1 (de) Immortalisierte menschliche Epithelzell-Linie aus Kornea
DK0755438T3 (da) Fremgangsmåde til bekæmpelse af metallophosphatpræcipitation i fermenteringer med høj celledensitet

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties